GlassScriptPhysician profile
John Tuan Pham
NPI 1912061623
$1,285.04
in general payments reported to CMS, 2019-2025
20 companies · $13.52 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $233 · 2021: $327 · 2022: $378 · 2024: $63.67 · 2025: $13.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $302.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.26 | 2019-2022 | |
| Novo Nordisk INC | $110.45 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.29 | 2019-2021 | |
| Lilly USA, LLC | $96.83 | 2020-2022 | |
| Pfizer INC. | $71.83 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $63.67 | 2024 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $63.01 | 2019-2021 | |
| Sanofi Pasteur INC. | $59.40 | 2019 | |
| Amarin Pharma, INC. | $54.41 | 2020-2021 | |
| Abbott Laboratories | $52.98 | 2022 | |
| Merck Sharp & Dohme LLC | $33.20 | 2019 | |
| Daiichi Sankyo INC. | $24.85 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $20.36 | 2022 | |
| Lucid Diagnostics INC. | $19.42 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $19.15 | 2022 | |
| Medtronic, INC. | $18.75 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.03 | 2021 | |
| Mdd US Operations, LLC | $13.52 | 2025 | Gocovri |
| Boston Scientific Corporation | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.